Bora Pharmaceutical Makes Strategic Appointment to Strengthen Global Manufacturing Capabilities
Bora Pharmaceuticals, a full-service contract development and manufacturing organization (CDMO), recently appointed Don Liscombe as its Vice President and General Manager to lead its flagship manufacturing facility in North America, located in Mississauga, Ontario, Canada.
Don will be responsible for leading the ambitious growth plans for the Mississauga facility and its current 400-strong workforce. Bringing a wealth of experience in pharmaceutical operations and the contract manufacturing industry, Don is recognized for driving profitable growth through customer service, employee engagement and a commitment to operational excellence. He has held progressively senior roles in the industry, including General Manager and most recently as leader of Regional Operational excellence at a global CDMO.
Commenting on his appointment, Don Liscombe said “I am privileged to serve in an industry that has a profound impact on people’s lives, and I am honoured to join the Bora team whose mission is Contributing to Better Health All Over the World. I am impressed by the company’s track record of delivering top-tier services to their customers, and I am truly excited to be joining them at a time of significant growth to reach more patient around the world”.
Bobby Sheng, CEO of Bora Pharmaceuticals, commented “We are delighted to be in a position to attract a leader like Don into the organization, he brings invaluable CDMO knowledge and experience to the team, and will help drive us toward our impressive growth strategy.
Bora Pharmaceuticals is a premier international CGMP CDMO specializing in complex oral solid dosage, liquids, nasal sprays, ophthalmic, and semi-solids pharmaceutical Rx and OTC products for Clinical through Commercial manufacturing and packaging. Bora owns and operates six state-of the-art CGMP manufacturing facilities (Taiwan and Canada) built to the highest international standards for manufacturing, packaging, R&D, and analytical testing. Our TAA-compliant sites deliver to more than 100 markets around the world including the US, Canada, EU, Southeast Asia, Middle East, and South and Central Americas. For more information, visit: www.boracorpcdmo.com.
Total Page Views: 850
